Compare
Picard Medical, Inc. vs Lucid Diagnostics Inc. vs Tenon Medical, Inc. vs Encision Inc
| Latest fiscal year | Picard Medical, Inc. PMI | Lucid Diagnostics Inc. LUCD | Tenon Medical, Inc. TNON | Encision Inc ECIALast annual report: year ended 2025-03-31 |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-03-31 |
| Revenue | $4.94M | $4.71M | $3.94M | $6.56M |
| Revenue growth (YoY) | +12.5% | +8.3% | +20.4% | -0.5% |
| Gross margin | -4.1% | -41.7% (computed) | 59.8% | 53.6% |
| Operating margin | -268.4% | n/m | -324.3% | -2.6% |
| Net margin | -546.6% | n/m | -318.4% | -3.4% |
| Net income | -$27.00M | -$58.01M | -$12.56M | -$220.2K |
| EPS (Diluted) | n/a | n/a | -$1.70 | -$0.02 |
| Operating cash flow | -$15.67M | -$46.48M | -$10.74M | -$54.9K |
| Free cash flow | n/a | -$46.68M | -$11.02M | -$109.4K |
| Cash & equivalents | $7.45M | n/a | $3.76M | $257.4K |
| Total assets | $22.55M | $40.45M | $10.76M | $3.67M |
| Total liabilities | $18.76M | $29.51M | $5.72M | $2.02M |
| Shareholders' equity | $3.79M | $10.94M | $5.04M | $1.65M |
| Return on year-end equity | -712.6% | -530.4% | -249.1% | -13.3% |
| Shares outstanding | 73.70M | 131.10M | 10.85M | 11.88M |
Revenue, most recent five fiscal years
| Fiscal year | Picard Medical, Inc. | Lucid Diagnostics Inc. | Tenon Medical, Inc. | Encision Inc |
|---|---|---|---|---|
| Latest | $4.94M Ended 2025-12-31 | $4.71M Ended 2025-12-31 | $3.94M Ended 2025-12-31 | $6.56M Ended 2025-03-31 |
| 1 year earlier | $4.39M Ended 2024-12-31 | $4.35M Ended 2024-12-31 | $3.28M Ended 2024-12-31 | $6.59M Ended 2024-03-31 |
| 2 years earlier | n/a | $2.43M Ended 2023-12-31 | $2.93M Ended 2023-12-31 | $7.35M Ended 2023-03-31 |
| 3 years earlier | n/a | $377.0K Ended 2022-12-31 | $691.0K Ended 2022-12-31 | $7.67M Ended 2022-03-31 |
| 4 years earlier | n/a | $500.0K Ended 2021-12-31 | $160.0K Ended 2021-12-31 | $7.54M Ended 2021-03-31 |